Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.

Daniela Di Giuda, Alessandro Giordano, Giorgio Treglia, Antonella Stefanelli, Fabrizio Cocciolillo, Ernesto Cason

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

34 Citazioni (Scopus)

Abstract

BACKGROUND AND PURPOSE: This study was designed to review the diagnostic performance of iodine-123-metaiodobenzylguanidine (MIBG) scintigraphy in differential diagnosis between Parkinson's disease (PD) and multiple-system atrophy (MSA). METHODS: A comprehensive computer literature search of studies published through March 2011 regarding MIBG scintigraphy in patients with PD and MSA was performed in PubMed/MEDLINE and Embase databases. Only studies in which MIBG scintigraphy was performed for differential diagnosis between PD and MSA were selected. Pooled sensitivity and specificity of MIBG scintigraphy were presented with a 95% confidence interval (CI). The area under the ROC curve was calculated to measure the accuracy of MIBG scintigraphy in differential diagnosis between PD and MSA. RESULTS: Ultimately, we identified 12 studies comprising a total of 1226 patients (593 patients with PD, 117 patients with other Lewy body disease, 129 patients with MSA, and 387 patients with other diseases). The pooled sensitivity of MIBG scintigraphy to detect PD was 89% (95% CI: 86-91%); the pooled specificity of MIBG scintigraphy to discriminate between PD and MSA was 77% (95% CI: 68-84%). The area under the ROC curve was 0.93. CONCLUSIONS: MIBG scintigraphy is an accurate test for PD detection and differential diagnosis between PD and MSA; this method shows high sensitivity and adequate specificity in this field. Nevertheless, possible causes of false negative and false positive findings should be considered when interpreting the scintigraphic results.
Lingua originaleEnglish
pagine (da-a)823-829
Numero di pagine7
RivistaClinical Neurology and Neurosurgery
Volume2011
Stato di pubblicazionePubblicato - 2011

Keywords

  • Metaiodobenzylguanidine
  • Parkinson's disease

Fingerprint

Entra nei temi di ricerca di 'Diagnostic performance of iodine-123-metaiodobenzylguanidine scintigraphy in differential diagnosis between Parkinson's disease and multiple-system atrophy: a systematic review and a meta-analysis.'. Insieme formano una fingerprint unica.

Cita questo